(Q50143642)
Statements
Efficacy and safety of the factor VIII/von Willebrand factor concentrate, haemate-P/humate-P: ristocetin cofactor unit dosing in patients with von Willebrand disease (English)
D Lillicrap
M C Poon
I Walker
F Xie
B A Schwartz
Association of Hemophilia Clinic Directors of Canada